### **Overview** Dr. Agarwal's Health Care Limited (DAHCL) is India’s **largest eye care service chain by revenue and number of facilities**, as validated by a January 2025 report from CRISIL. Founded in 1957 in Chennai as a single hospital, the company has evolved into a dominant national and international provider of comprehensive ophthalmic care. It is listed on both the **BSE and National Stock Exchange (NSE)** of India. The company operates under a focused **single-specialty hospital model**, allowing for clinical excellence, cost-efficient scalability, and advanced technology adoption. Its asset-light, hub-and-spoke delivery system supports rapid geographic expansion and efficient utilization of medical resources. --- ### **Geographic Footprint & Network Size** - **Total Facilities (as of September 30, 2025):** **258** eye care centers - **India:** 239 facilities across 14 states and 5 Union Territories, serving **129 cities** - **Tier-I Cities:** 79 facilities - **Other Cities (Tier-II/III & rural):** 160 facilities - **Africa:** 19 facilities across **9 countries** – Mauritius, Mozambique, Rwanda, Uganda, Kenya, Tanzania, Madagascar, Ghana, and Zambia > *The network expanded rapidly from 221 facilities (Dec 2024) to 258 by end-Sept 2025, adding 37 new centers in under 10 months – reflecting sustained growth momentum.* - The company has achieved a **29.7% CAGR in facility count** from FY2022 to Q1 FY2026, driven by both organic launches and strategic acquisitions. --- ### **Business Model & Operational Strategy** #### **1. Hub-and-Spoke Model** - A **tiered network structure** comprising: - **28 Tertiary Care "Hub" Hospitals** (including 3 Centres of Excellence in Chennai, Tirunelveli, and Cuttack) - **Secondary (Spoke) Centers:** Day-care surgical units - **Primary (Spoke) Clinics:** Focused on diagnostics, consultations, and early referrals - **Advantages:** - Enables seamless patient referral pathways - Optimizes doctor and equipment utilization - Delivers standardized, high-quality care across locations - Reduces capital intensity through shared infrastructure #### **2. Asset-Light Expansion** - Nearly **all facilities are leased**, with only one company-owned location. - This minimizes upfront capital expenditure, enabling **rapid deployment** in both metro and underserved areas. #### **3. Clinical Excellence & Standardization** - **Clinical Board:** Led by senior ophthalmologists; ensures adherence to uniform clinical benchmarks. - **Specialty Advisory Board:** Provides expert guidance in subspecialties (Cataract, Retina, Cornea, Glaucoma, etc.). - **International Advisory Board:** Aligns care standards with global benchmarks (ASCRS, AAO, EuCornea). --- ### **Services Offered** DAHCL provides a **complete spectrum of eye care services**, including: - **Surgical Treatments:** Cataract (73% of surgeries), refractive (SMILE, Femto-LASIK), corneal, retinal, glaucoma, pediatric, neuro-ophthalmology, oculoplasty - **Diagnostics & Consultations** - **Non-Surgical Management** - **Optical Retail:** Eyewear, contact lenses, accessories - **Pharmaceutical Sales:** Eye drops, ointments, and formulations - Digital platforms for **e-reports, EMR-integrated workflows**, and teleconsultation --- ### **Clinical Innovation & Technology** - **Pioneered Techniques:** Glued IOL, Phakonit, PDEK, CAIRS, CACXL – recognized globally and adopted internationally. - **Digital Transformation:** - EMR system with daily validation of ~950 reports by optometrists - E-report platform upgraded in FY25 to **Spring Boot & Docker architecture** for scalability - Available in **6 regional languages** (Tamil most widely used) - Patient engagement via **WhatsApp campaigns, walk-through videos**, and behavioral dashboards - **Technology-Driven Expansion:** SMILE and femto cataract surgeries deployed across key centers as differentiators --- ### **Growth Strategy** #### **Dual Growth Engine** - **Organic Expansion:** 108 new facilities opened since FY2022 - **Inorganic Growth:** 52 facilities acquired since FY2022 - Notable acquisitions: **Thind Eye Hospital (₹257.08 crores)**, including opticals and medicines arm - Recent minority stake acquisition: **12.25% in Aditya Jyot Eye Hospital (October 2025)** via subsidiary Orbit Healthcare #### **Cluster-Based Approach** - Identifies **micro-markets ("clusters")** using demographic, demand, and competitive analysis - Focus on **underserved towns and rural areas** to expand access and capture unmet need - In mature markets (e.g., Tamil Nadu), expansion is organic; in underpenetrated regions (e.g., North India), entry via acquisition followed by organic scaling #### **Regional Expansion Highlights (FY2025–2026)** | Region | Key Developments | |-------|------------------| | **South India** | +40 facilities (14 surgical); leadership in Tamil Nadu, Karnataka, Telangana, Andhra Pradesh | | **West India** | +5 surgical centers in Maharashtra & Gujarat; growth driven by Mumbai acquisitions | | **North India** | Entry into **Delhi NCR** with first **9,000 sq ft tertiary facility**, led by Padma Shri Dr. Jeewan Titiyal | | | +9 facilities (5 surgical); expansions in Punjab, Uttar Pradesh (Varanasi), Jammu & Kashmir | | **Africa** | Steady organic growth; plans to open 2–3 new facilities annually. Operations **self-sustaining**, with ₹9–12 crores repatriated annually to India | --- ### **Market Presence & Financials (FY2025 / First Half FY2026)** - **Revenue (9M FY2025):** ₹1,250.8 crores (+27.2% YoY) - **EBITDA (9M FY2025):** ₹356.0 crores - **India Contribution:** 89.9% of revenue - **Revenue Mix:** - **Surgical Services:** >65% - **Optical & Pharmacy Sales:** 21% - **Consultations & Diagnostics:** 14% - **Market Share:** ~25% in **organized eye care market** – 1.7x larger than nearest competitor - **Organized Market Penetration:** Only 13–15% of Indian eye care market is organized; significant opportunity remains --- ### **Patient & Clinical Metrics (as of Sept 30, 2025)** - **Patients Served (12 months ended Mar 2025):** 2.43 million - **Surgeries Performed (FY2025):** 282,326+ - **Q1 FY2026 (Apr–Jun 2025):** - Over **7 lakh patients** - ~**79,000 surgeries** - Supported by **850+ doctors** - **Medical Workforce (Mar 2025):** - 831 doctors - 1,849 paramedics - 2,680 total clinical professionals --- ### **Subsidiary & Manufacturing Arm** - **Orbit Healthcare Services (Mauritius) Ltd.:** - Holds **8 downstream subsidiaries** - Engaged in **design, manufacturing, import/export of ophthalmic diagnostic devices**: - Auto perimeters - Optical biometers - Ophthalmoscopes - Reinforces vertical integration and quality control across the care chain --- ### **Competitive Landscape** DAHCL competes with both national chains and strong regional institutions: - **Key Competitors:** - Centre for Sight - ASG Eye Hospitals - Maxivision - Aravind Eye Hospital - Sankara Nethralaya - Narayana Nethralaya - LV Prasad Eye Institute - Eye Foundation - **DAHCL’s Differentiators:** - **Scale leadership** (largest by revenue and network) - **Hub-and-spoke efficiency** - **Asset-light agility** - **Proven clinical innovation** - **Digital-first patient engagement** ---